ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) Director Michael Swinford bought 16,471 shares of the stock in a transaction dated Wednesday, November 20th. The shares were bought at an average price of $1.84 per share, for a total transaction of $30,306.64. Following the completion of the acquisition, the director now owns 26,511 shares in the company, valued at approximately $48,780.24. The trade was a 164.05 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
ReWalk Robotics Trading Up 8.4 %
Shares of LFWD opened at $2.07 on Tuesday. The firm has a 50-day moving average price of $2.58 and a 200 day moving average price of $3.52. ReWalk Robotics Ltd. has a 12-month low of $1.70 and a 12-month high of $9.10. The firm has a market capitalization of $18.24 million, a P/E ratio of -0.83 and a beta of 2.07.
ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.08). ReWalk Robotics had a negative return on equity of 43.02% and a negative net margin of 77.21%. The firm had revenue of $6.13 million for the quarter, compared to analyst estimates of $8.38 million. During the same quarter in the prior year, the business earned ($0.56) EPS. Equities research analysts predict that ReWalk Robotics Ltd. will post -1.78 earnings per share for the current fiscal year.
Analyst Ratings Changes
View Our Latest Stock Analysis on LFWD
Institutional Investors Weigh In On ReWalk Robotics
A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP acquired a new position in ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics as of its most recent filing with the Securities and Exchange Commission. 26.76% of the stock is owned by hedge funds and other institutional investors.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Articles
- Five stocks we like better than ReWalk Robotics
- What Does a Stock Split Mean?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Differences Between Momentum Investing and Long Term Investing
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Roth IRA Calculator: Calculate Your Potential Returns
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.